Clinical Trial Update: Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating corifollitropin alfa followed by hpHMG in a long GnRH agonist protocol for poor ovarian responders with infertility; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Poor Ovarian Response

Drugs mentioned

• Corifollitropin alfa (Corifollitropin alfa)
• hpHMG (hpHMG)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility, Poor Ovarian Response | Phase 2 | Status: COMPLETED